Universal Corporation (NYSE: UVV) — Form 10-Q summary
Period: The supplied filing is for the quarter ended September 30, 2022 (Universal’s fiscal 2023 second quarter), with six-month year-to-date results. This differs from the request metadata, which says 2021 Q2. Financial amounts below are in millions unless stated otherwise.
Business context and results
Universal is a global business-to-business supplier of leaf tobacco and plant-based food ingredients. Its business is seasonal, and quarterly results may not indicate full-year performance. Management said demand remained strong in both segments; tobacco shipments improved as container and vessel availability eased, particularly in Brazil.
| Metric | Three months ended Sept. 30, 2022 | Six months ended Sept. 30, 2022 | Comparable 2021 period |
|---|---|---|---|
| Revenue | $651.0; +43% year over year | $1,080.8; +34% | $454.0 quarter; $804.0 six months |
| Operating income | $37.9; +27% | $51.2; +27% | $29.8 quarter; $40.4 six months |
| Net income attributable to Universal | $21.9 | $28.7 | $19.5 quarter; $25.9 six months |
| Diluted EPS | $0.88 | $1.15 | $0.78 quarter; $1.04 six months |
| Gross margin | Not separately stated in the filing’s highlights | 17.6%, down 170 basis points | 19.3% six months |
Segment operating income for the first half was $41.9 for Tobacco Operations, up 17%, and $9.1 for Ingredients Operations, up 29%. Tobacco revenue growth reflected higher shipment volumes and prices, including carryover tobacco; some shipments were lower margin. Ingredients growth reflected Shank’s, acquired in October 2021, as well as higher volumes and prices.
Cash flow, balance sheet, and liquidity
- Operating cash flow: Cash used was $346.2 in the six months, versus $120.8 used in the prior-year period. Management attributed the larger use mainly to higher tobacco costs and the timing of purchases and shipments.
- Investing and financing: Capital expenditures were $26.6; net cash used in investing was $23.8. Financing provided $349.2, including $399.9 of net short-term debt issuance. Common dividends paid were $38.6.
- Cash and working capital: Cash and cash equivalents were $58.9 at September 30, 2022; the cash flow statement also reports $6.0 of restricted cash. Tobacco inventory was $968.2, up $145.7 from March 31, 2022. Accounts receivable was $469.4.
- Debt and liquidity: Short-term notes payable and overdrafts were $582.4, and long-term debt was $518.9. Net debt to net capitalization was about 44%, versus 33% a year earlier and 32% at March 31, 2022. The company reported $100 of committed revolving credit availability and about $56 of uncommitted lines; it was in compliance with debt covenants.
- Capital spending: Management expected $40–$50 of capital projects over the next 12 months.
Changes, outlook, and risks
- Revenue and operating income rose, but first-half gross margin declined as cost of goods sold grew faster than revenue, primarily due to lower-margin tobacco sales. SG&A increased with Shank’s, foreign currency effects, and higher compensation and travel costs.
- Interest expense increased to $19.0 for the first half from $13.3, largely due to higher debt balances and interest rates. The effective tax rate was 31.1%; the Tanzania sale added $1.1 of tax, while reducing interest expense by $1.8 through removal of an uncertain tax position.
- Management said peak seasonal working-capital needs had passed, cited significant receipts in October, and expected debt to decline over the next two fiscal quarters as shipments and customer collections occur. No specific earnings guidance was provided.
- Tobacco inventories were nearly 90% committed for sale at September 30. Management noted undersupply across leaf types, short African burley crops due largely to weather, and remaining shipping constraints in some regions.
- Key uncertainties include seasonal working capital and shipment timing, inflation and supply-chain costs, foreign exchange and interest rates, customer concentration, COVID-19 developments, geopolitical and weather conditions, and regulatory or tax matters. Brazilian VAT assessments have reasonably possible losses of up to approximately $9 and $3, respectively; management considers losses not probable and has recorded no liability.
- The company sold its idled Tanzania operations for $8.5, receiving $1.3 at closing in June 2022, with remaining proceeds expected in installments by June 2023. It also authorized a new $100 share repurchase plan through November 15, 2024.
Important facts for investors to verify
- Confirm the intended reporting period: the supplied filing covers the quarter ended September 30, 2022, not 2021 Q2.
- Track seasonal inventory, receivables, operating cash use, and whether expected customer collections reduce short-term borrowing as management anticipated.
- Assess whether shipment growth and tobacco availability support margins, given lower-margin sales and continued crop and logistics constraints.
- Monitor interest expense, variable-rate exposure, and covenant headroom; the filing estimates a 1% short-term rate increase would add about $7.3 of annual interest expense before partial customer-charge offsets.
- Review outcomes of the Brazilian VAT assessments and collection of the remaining Tanzania sale proceeds.